Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta.

Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M.

J Biol Chem. 2002 Jun 7;277(23):20399-408. Epub 2002 Mar 27.

2.

Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion?

Vandenbunder B, Wernert N, Queva C, Desbiens X, Stehelin D.

Folia Biol (Praha). 1994;40(5):301-13. Review.

PMID:
7534726
3.

Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development.

Vandenbunder B, Queva C, Desbiens X, Wernert N, Stehelin D.

Invasion Metastasis. 1994-1995;14(1-6):198-209. Review.

PMID:
7657513
4.

Fibrogenesis. V. TGF-beta signaling pathways.

Wells RG.

Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G845-50. Review.

5.

The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis.

Ghosh AK, Varga J.

J Cell Physiol. 2007 Dec;213(3):663-71. Review.

PMID:
17559085
6.

TGF-beta and fibrosis in different organs - molecular pathway imprints.

Pohlers D, Brenmoehl J, Löffler I, Müller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G.

Biochim Biophys Acta. 2009 Aug;1792(8):746-56. doi: 10.1016/j.bbadis.2009.06.004. Epub 2009 Jun 17. Review.

7.

ETS-targeted therapy: can it substitute for MEK inhibitors?

Tetsu O, McCormick F.

Clin Transl Med. 2017 Dec;6(1):16. doi: 10.1186/s40169-017-0147-4. Epub 2017 May 2. Review.

8.

Review of Ets1 structure, function, and roles in immunity.

Garrett-Sinha LA.

Cell Mol Life Sci. 2013 Sep;70(18):3375-90. doi: 10.1007/s00018-012-1243-7. Epub 2013 Jan 5. Review.

Supplemental Content

Support Center